Revance Therapeutics (RVNC) Prices 3.25M Common Offering at $36/Share
Tweet Send to a Friend
Revance Therapeutics (NASDAQ: RVNC) announced the pricing of its underwritten public offering of 3,250,000 shares of its common stock ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
